Swiss drugmaker Roche Holding AG said a new study of cancer drug Avastin showed it significantly extended progression-free survival of people with an aggressive form of brain cancer
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment